⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL304451 | 0.74 | — | — | |
| SCHEMBL6136492 | 0.74 | — | — | |
| SCHEMBL4992062 | 0.74 | — | — | |
| SCHEMBL6136576 | 0.74 | — | — | |
| SCHEMBL1008408 | 0.74 | — | — | |
| SCHEMBL11730335 | 0.72 | LMNA (0.43) | — | |
| SCHEMBL17648125 | 0.69 | HDAC8 (0.31) | — | |
| SCHEMBL2160030 | 0.69 | PLCG1 (0.31) | — | |
| SCHEMBL10330647 | 0.69 | IDH1 (0.37) | — | |
| SCHEMBL18549510 | 0.67 | POLB (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019181645-A1 | COMPOUND, PRECURSOR TO COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL INCLUDING COMPOUND, AND ORGANIC ELECTRONIC DEVICE INCLUDING ORGANIC SEMICONDUCTOR MATERIAL | 国立大学法人大阪大学 | 2019-09-26 | — | — | WO | disclosed |
| WO-2019181646-A1 | MACROMOLECULAR COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL INCLUDING MACROMOLECULAR COMPOUND, AND ORGANIC ELECTRONIC DEVICE INCLUDING ORGANIC SEMICONDUCTOR MATERIAL | 国立大学法人大阪大学 | 2019-09-26 | — | — | WO | disclosed |
| WO-2019078040-A1 | COMPOUND, BONDED BODY OF SAME, AND ORGANIC SEMICONDUCTOR MATERIAL | 国立大学法人大阪大学 | 2019-04-25 | — | — | WO | disclosed |
| US-9675593-B2 | Anti-fibrotic pyridinones | INTERMUNE, INC. (US) | 2017-06-13 | — | — | US | disclosed |
| US-20170121345-A1 | ANTI-FIBROTIC PYRIDINONES | GENENTECH, INC. | 2017-05-04 | — | — | US | disclosed |
| US-20160263090-A1 | ANTI-FIBROTIC PYRIDINONES | GENENTECH, INC. | 2016-09-15 | — | — | US | disclosed |
| US-9359379-B2 | Anti-fibrotic pyridinones | INTERMUNE, INC. (US) | 2016-06-07 | — | — | US | disclosed |
| US-20140107110-A1 | ANTI-FIBROTIC PYRIDINONES | GENENTECH, INC. | 2014-04-17 | — | — | US | disclosed |
| EP-1435953-A4 | ANTIVESICANT COMPOUNDS AND METHODS OF MAKING AND USING THEREOF | US ARMY MED RES MAT COMMAND (US) | 2005-05-04 | — | — | EP | disclosed |
| EP-1435953-A1 | ANTIVESICANT COMPOUNDS AND METHODS OF MAKING AND USING THEREOF | U.S. Army Medical Research and Materiel Command (US) | 2004-07-14 | — | — | EP | disclosed |
| US-6664280-B2 | For decontaminating an area exposed to a vesicant agent; for therapy of prophylaxis or inhibiting injuries induced by a vesicant agent, such as bis-2-chloroethylsulfide (HD) | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY | 2003-12-16 | — | — | US | disclosed |
| US-20030055090-A1 | Antivesicant compounds and methods of making and using thereof | LG DISPLAY CO., LTD. (KR) | 2003-03-20 | — | — | US | disclosed |
| WO-2003011292-A1 | ANTIVESICANT COMPOUNDS AND METHODS OF MAKING AND USING THEREOF | U.S. ARMY MEDICAL RESEARCH AND MATERIEL COMMAND (US) | 2003-02-13 | — | — | WO | disclosed |